Andrew J. Einhorn - 24 Jan 2022 Form 4 Insider Report for RVL Pharmaceuticals plc (RVLP)

Role
Chief Financial Officer
Signature
/s/ Christopher Klein, as attorney-in-fact
Issuer symbol
RVLP
Transactions as of
24 Jan 2022
Transactions value $
$-10,856
Form type
4
Filing time
26 Jan 2022, 15:31:55 UTC
Previous filing
08 Nov 2021
Next filing
15 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVLP Ordinary Shares Tax liability $-10,856 -9,607 -6.36% $1.13 141,473 24 Jan 2022 Direct
holding RVLP Ordinary Shares 22,852 24 Jan 2022 By family limited liability company F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is the sole managing member of the limited liability company and, as a result, may be deemed to beneficially own the ordinary shares held by the limited liability company. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.